News about Global Pharma

Zydus Gets Final Approval from USFDA for Darunavir Tablets 600 mg and 800 mg and Tentative Approval for 75 mg and 150 mg Tablets

Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") has received final approval from the United States Food and Drug Administration (USFDA) for Darunavir Tablets 600 mg and 800 mg, and tentative approval for 75 mg and 150 mg tablets (USRLD: Prezista® Tablets, 75 mg, 150 mg, 600 mg, and 800 mg).

Global Pharma | 18/12/2023 | By Manvi |  733

Cipla Limited Invests INR 42 Crore in GoApptiv Private Limited

In line with Cipla’s ambition to strengthen investments in channels of the future, this development will further expand Cipla’s presence across the healthcare continuum, especially to the underserved population by enabling greater access to lifesaving treatments.

Global Pharma | 18/12/2023 | By Manvi |  323

Aptar Pharma Unveils the Grand Opening of its New Mumbai Facility

Aptar Pharma Inaugurates its New Aptar Mumbai Site to Increase Manufacturing Capabilities in South East Asia

Global Pharma | 18/12/2023 | By Manvi |  641

Alkermes Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Under the terms of the agreement, upon the closing of the transaction, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets, subject to customary adjustments in accordance with the agreement.

Global Pharma | 15/12/2023 | By Manvi |  853

Teda Smart Pharma, Asrega Ink MoU to Tap Malaysia's Growing Vending Machine Market

Malaysia's vending machine market has been steadily expanding in recent years due to shifting consumer tastes and rising demand for easy-to-shop options.

Global Pharma | 15/12/2023 | By Manvi |  738

Aptamer Group Signs Material Agreement with Genetic Medicines Company

Under the terms of the agreement, Aptamer Group will use its proprietary platform to discover Optimer binders to enable the specific targeting of genetic medicines to specific cell types.

Global Pharma | 15/12/2023 | By Manvi |  395

Romaco Kilian Tableting Workshop Jointly with BASF

The aim of the event was to develop a pediatric formulation, from prototype to production scale. Live demonstrations from the Kilian laboratory in Cologne were complemented by scientific presentations on the subject of formulation and tableting.

Global Pharma | 15/12/2023 | By Manvi |  289

Lek Pharma Starts USD 400 Million Biologics Facility Construction in Slovenia

The ambitious initiative was set into motion after Sandoz, the parent company of Lek Pharmaceuticals and a global leader in generic and biosimilar medicines, unveiled plans for this state-of-the-art production center in March 2023.

Global Pharma | 14/12/2023 | By Manvi |  2360

BioNTX Announces 10th Annual iC Summit and Support of International Pharma Logistics Masterclass

BioNTX to support DFW Airport's announcement of the upcoming 2024 edition of the Pharma Logistics Masterclass at Pegasus Park.

Global Pharma | 14/12/2023 | By Manvi |  670

Sun Pharma's Specialty Product Ilumetri Included in China's National Reimbursement Drug List

Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Global Pharma | 14/12/2023 | By Manvi |  1028